Radiosensitization With Veliparib Promising in Inflammatory Breast Cancer

The rate of severe acute toxicity was relatively low in a study of radiosensitization with veliparib for patients with inflammatory or locally recurrent breast cancer.

Source: CancerNetwork - March 28, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Source Type: news